- Screener
- Securities US
- Johnson & Johnson
Johnson & Johnson
$156.92
-$0.52
-0.33%
21 Apr 20:00
$140.68
$169.99
52 weeks low/high
Market sentiment
Section about market participants' moods: bulls holding long positions (“longs”) and bears holding short positions (“shorts”).
Overall assessment
bullish sentiment increases
Long
100.00%Short
0.00%| Index | Bulls | Bears |
|---|---|---|
Confidence | — | |
Support | ||
Cash flows | — |
Momentum
Indicators for analyzing trends in the instrument. Based on them you can choose the optimal moment to open or close a position.
Return/MDD
0.96Sentiment
BearishStart Date
04.01.2025Duration
16Yield
2.76%Avg.Yield
1.21%
Volatility
1.71%Max MDD
-2.89%Avg. MDD
-6.44%Min Price
RUB 148.63Max Price
RUB 160.25
Protective stop levels
S/L 5%RUB 161.61 | S/L 10%RUB 169.30 | S/L 15%RUB 177.00 | |
|---|---|---|---|
Day | 13.02% | 0.00% | 0.00% |
Week | 49.85% | 5.86% | 0.23% |
Month | 74.12% | 35.60% | 13.64% |
Technical analysis
- Trend ClassTurning down
- Trend PowerAlmost flat
- PatternChannel
- EMA-20Bullish reversalThe price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.
- EMA-50Bullish reversalThe price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.
- EMA-100Bullish reversalThe price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.
- StochasticBullish weakeningThe stochastic indicator is in overbought territory and it falls. These factors indicate that perhaps the upside trend is coming to an end. Last signal: main and signal line crossing.
- RSIBullishRSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.
- MACDBullish reversalOscillator MACD is in the negative territory it crossed the signal line from the bottom and grows. These factors mean that the market confirms the end of the downward trend. Last signal: main and signal line crossing.
- Candle pattern typeBullish Three Inside UpPattern is a made up of three candlesticks. Big black candlestick appears on the first day in a downtrend. The second day body is engulfed by the body of the first day. A white candlestick on the third day with a higher close than the second day. Considered to be a bullish reversal pattern.Date of signal:
Prices and risks
Price
| Change | Change by industry | Min. | Max. | Volume | |
|---|---|---|---|---|---|
| Yesterday | 0.31% | 4.11% | $154.16 | $159.44 | 1.00B |
| Week | 2.29% | 1.96% | $151.17 | $159.44 | 3.34B |
| Month | -3.39% | 0.15% | $141.50 | $166.63 | 17.80B |
| 3 Months | 6.61% | 5.36% | $141.50 | $169.99 | 50.15B |
| 6 Months | -3.00% | 19.73% | $140.68 | $169.99 | 84.80B |
| Year | 6.80% | 0.64% | $140.68 | $169.99 | 147.83B |
| 3 years | -13.86% | 56.01% | $140.68 | $186.69 | 522.07B |
| 5 years | 5.44% | 76.51% | $133.65 | $186.69 | 856.76B |
| All time | 226.69% | 54.85% | $46.25 | $186.69 | 843.88B |
Volatility
| JNJ | By industry | |
|---|---|---|
| Yesterday | 46.27% | 1.03% |
| Week | 1.93% | 1.76% |
| Month | 5.69% | 9.54% |
| 3 Months | 9.04% | 20.61% |
| 6 Months | 11.80% | 29.79% |
| Year | 19.17% | 41.76% |
| 3 years | 29.76% | 90.20% |
| 5 years | 37.73% | 117.61% |
| All time | — | — |
- Sortino
- 0.37
- Sharpe
- 0.46
- Sterling
- -0.50
- Liquidity index
- 7.59
- Alpha
- -0.00041
- Beta
- 0.34
AI Factors
Drivers of growth or decline are external factors, selected using AI, that can significantly affect the price of a company's shares in the future.
Fundamental analysis
Indicators for the last quarter and their dynamics for 5 quarters
Ratios
Valuation
Debts
Efficiency
Other ratios
Revenue
Financials
Growth
Assets
Debts
News
About
$379.48B
Capitalization
2.41B
Shares outstanding
Health Care
Sector
Pharmaceuticals
Industry
US4781601046
ISIN
1
Lot size
Mr. Joaquin Duato
CEO
Website
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.